COVID-19 Eliminating Onsite Monitoring Visits in Clinical Studies; MANA RBM Has the Immediate Remote Risk Based Monitoring Solution

March 17, 2020

MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now. 

MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study.  Subject review can begin within days.

"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM.  "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."

Here is the link to the head to head comparison:

See the latest posts on our homepage


Topic Area: Press Release

Recent Posts
Recent Posts

Florida Assisted-Living Facilities No Longer Required To Test Staff For COVID

Federal guidelines require nursing homes to continue testing


Pandemic Hastening Closure Of Some Urban Hospitals

COVID has worsened the situation for already weakened hospitals


Georgia Blocks ‘Granny Cam’ Legislation

Some in the long-term care industry have opposed cameras



Tackling the Pandemic with Environmental Monitoring

The benefits of temperature and environmental monitoring are twofold


Regulations, Codes & Standards Q&A: More On Power Strips

Brad Keyes discusses regulations related to power strips


Post Comment


News & Updates • Webcast Alerts • Building Technologies

All fields are required.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.